Showing results (81-90 of 212) with videos related to
Sort By:
Pageof 22
International Review of Neurobiology|November 5, 2011
Proteomic technologies for biomarker studies in psychiatry: advances and needsDaniel Martins-de-Souza, Paul C Guest, Natacha Vanattou-Saifoudine, et al.International Review of Neurobiology|November 5, 2011
Abnormalities in metabolism and hypothalamic-pituitary-adrenal axis function in schizophreniaPaul C Guest, Daniel Martins-de-Souza, Natacha Vanattou-Saifoudine, et al.Journal of Neurochemistry|June 13, 2009
Apolipoprotein-D expression is increased during development and maturation of the human prefrontal cortexWoojin S Kim, Jenny Wong, Cynthia Shannon Weickert, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 23, 2017
Lithium reverses behavioral and axonal transport-related changes associated with ANK3 bipolar disorder gene disruptionMichael G Gottschalk, Melanie P Leussis, Tillmann Ruland, et al.Journal of Separation Science|March 30, 2007
CSF biomarker discovery using label-free nano-LC-MS based proteomic profiling: technical aspectsJeffrey T J Huang, Therese McKenna, Chris Hughes, et al.European Archives of Psychiatry and Clinical Neuroscience|December 10, 2009
The role of proteomics in depression researchDaniel Martins-de-Souza, Laura W Harris, Paul C Guest, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 6, 2008
Real-time evaluation of experimental variation in large-scale LC-MS/MS-based quantitative proteomics of complex samplesYishai Levin, Lan Wang, Erin Ingudomnukul, et al.Molecular Autism|July 26, 2014
Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disordersHendrik Wesseling, Paul C Guest, Chi-Ming Lee, et al.Schizophrenia Research|June 24, 2016
Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathologyDavid A Cox, Michael G Gottschalk, Hendrik Wesseling, et al.The International Journal of Neuropsychopharmacology|November 16, 2013
The need for a comprehensive molecular characterization of autism spectrum disordersJantine A C Broek, Eva Brombacher, Viktoria Stelzhammer, et al.Pageof 22